South African Babies Hold TB Vaccine Hopes
March 29, 2011
Almost 2,800 babies are enrolled in a two-year study of a TB vaccine candidate hailed by some as the most exciting advance since the 1921 debut of the BCG vaccine, which is still used today.
The study is underway in Worcester, an area in South Africa's wine country about 75 miles northeast of Cape Town. Babies are receiving either the vaccine or a placebo and will be monitored for two years to check if they develop TB. The study's first results are expected in mid-2012.
Agence France Presse
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)